Predictive Biomarker Panels and Next-Generation Sequencing Co-Developed with Targeted Biologics
Uniting diagnostic assay development with targeted biopharmaceutical discovery is solidifying companion diagnostics (CDx) as the cornerstone of precision oncology. Detailed analysis within the Companion Cancer Diagnostics Market report reveals how FDA-approved immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and NGS gene panels identify actionable tumor mutations....
0 Comments 0 Shares 161 Views 0 Reviews